Adenovirus-mediated gene transfer into striated muscles

Journal of Molecular Medicine

Volumn 73, Issue 4, 1995, Pages 165-180

  Acsadi, G ^a   Jani, A ^a   Massie, B ^b  

^a MCGILL UNIVERSITY   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Adenovirus; Gene therapy; Neuromuscular disorders

Indexed keywords

ADENOVIRUS; BECKER MUSCULAR DYSTROPHY; DUCHENNE MUSCULAR DYSTROPHY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; MOLECULAR GENETICS; NEUROMUSCULAR DISEASE; REVIEW;

ADENOVIRIDAE; ANIMAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMAN; MUSCLE, SKELETAL; NEUROMUSCULAR DISEASES;

EID: 0028898039     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/BF00188137     Document Type: Review

References (175)

1. Direct gene transfer and expression into rat heart in vivo
2. Human dystrophin expression in mdx mice after injection of DNA constructs
3. A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity
4. Cultured human myoblasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants
5. The structural and functional diversity of dystrophin
6. A mechanism by which adenovirus virus-associated RNA1 controls translation in a transient expression assay
7. Transfer of a foreign gene into the brain using adenovirus vectors
8. Expression of a recombinant dystrophin in mdx mice using adenovirus vector
9. Expression of bicistronic measles virus P/CmRNA by using hybrid adenoviruses: levels of C protein synthesized in vivo are unaffected by the presence or absence of the upstream P initiator codon
10. High-level eukaryotic in vivo expression of biologically active measles virus hemagglutinin by using an adenovirus type 5 helper-free vector system
11. Human gene therapy
12. Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport
13. Vitronectin receptor antibodies inhibit infection of HeLa cells and A549 cells by adenovirus type 12 but not by adenovirus type 2
14. In vitro and in vivo synthesis of the hepatitis B virus surface antigen and of the receptor for polymerized human serum albumin from recombinant adenoviruses
15. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus
16. Improved diagnosis of Duchenne/Becker muscular dystrophy
17. Functions of adenovirus E1A
18. Expression of dihydrofolate reductase and of the adjacent E1B region in an Ad5-dihydrofolate reductase recombinant virus
19. Effect of the tripartite leader on synthesis of a non-viral protein in an adenovirus 5 recombinant
20. Abundant expression of polyomavirus middle T antigen and dihydrofolate reductase in an adenovirus recombinant
21. Development of adenovirus vectors for the expression of heterologous genes
22. Packaging capacity and stability of human adenovirus type 5 vectors
23. An efficient and flexible system for construction of adenovirus vectors with insertion or deletions in early regions 1 and 3
24. Transformation by human adenoviruses
25. Redundant control of adenovirus late gene expression by early region 4
26. X-chromosome-linked muscular dystrophy (MDX) in the mouse
27. The subcellular distribution of dystrophin in mouse skeletal cardiac and smooth muscle
28. The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2
29. Gene therapy for muscle diseases
30. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity
31. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis
32. Dystrophin expression improves myofiber survival in mdx muscle following intramuscular plasmid DNA injection
33. Overproduction of polyomavirus middle T antigen in mammalian cells through the use of an adenovirus vector
34. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector
35. Expression of hepatitis B surface antigen with a recombinant adenovirus
36. Human adenovirus-host cell interactions: comparative study with members of subgroups B and C
37. Systemic delivery of human growth hormone by injection of genetically engineered myoblasts
38. Retroviral-mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitro
39. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses
40. Prolonged transgene expression in Cotton rat lung with recombinant adenoviruses defective in E2A
41. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin
42. Membrane organization of the dystrophin-glycoprotein complex
43. Lytic infection by adenoviruses
44. Progress toward human gene therapy
45. Adenovirus E1A represses protease gene expression and inhibits metastasis in human tumor cell
46. Antioncogenic effect of adenovirus E1A in human tumor cells
47. The muscular dystrophies
48. Scale-up of the adenovirus expression system for production of recombinanl protein in human 293S cells
49. Cis-acting induction of adenovirus transcription
50. Role of early region 3 (E3) in palhogenesis of adenovirus disease
51. Binding of the adenovirus VAI RNA to the interferon induced 68-kD protein kinase correlated with function
52. Helper-free adenovirus type 5 vectors
53. A 14 700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor
54. Human adenovirus cloning vectors based on Infectious bacterial plasmids
55. Protein IX a minor component of human adenovirus capsid is essential for the packaging of full length genomes
56. Rabies and Borna disease. A comparative pathogenetic study of two neurovirulent agents
57. Transformation and oncogenicity of human adenoviruses
58. Growth of 293 cells in suspension culture
59. A new technique for the assay of infectivity of human adenovirus 5
60. Manipulation of adenovirus vectors
61. Adenovirus-based expression vectors and recombinant vaccines
62. Characteristics of a human cell line transformed by DNA from human adenovirus 5
63. Cis and trans requirements for the selective packaging of the adenovirus type 5 DNA
64. Stepwise dismantling of adenovirus 2 during entry into cells
65. Biochemical studies on adenovirus multiplication. XII. Plaquing efficiencies of purified human adenoviruses
66. Towards understanding skeletal muscle regeneration
67. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans
68. Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene
69. Development of a helper independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene
70. Expression of dystrophin minigenes in the muscles of mdx mice partially prevents the development of dystrophic symptomes
71. The origin of adenovirus DNA replication: minimal DNA sequence requirement in vivo
72. Integrins: versatility modulation and signaling in cell adhesion
73. Motoneuron survival factors: biological roles and therapeutic potential
74. Nucleotide sequence of adenovirus 2 DNA fragment encoding for the carboxylic region of the fiber protein and the entire E4 region
75. Dystrophin: the protein product on the Duchenne muscular dystrophy locus
76. Gene transfer into skeletal muscles by isogenic myoblasts
77. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants
78. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix
79. High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector protection elicited in a murine model
80. Abundant expression of herpes simplex virus glycoprotein gB using an adenovirus vector
81. Inhibition of interferon-inducible gene expression by adenovirus E1A proteins: block in transcriptional complex formation
82. Expression of immunoreactive major histocompatibility complex products in human skeletal muscles
83. Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy
84. The potential for gene therapy in Duchenne muscular dystrophy and other genetic muscle diseases
85. Myoblast transfer in Duchenne muscular dystrophy
86. The principles of gene therapy in Duchenne muscular dystrophy
87. Adenovirus DNA replication
88. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals
89. Muscular dystrophy in a litter of golden retriever dogs
90. Identification of a cellular transcription factor involved in E1A transactivation
91. High level of expression in 293 cells of herpes simplex virus type 2 ribonucleotide reductase subunit 2 using an adenovirus vector
92. Identification and characterization of a spinal muscular atrophy-determining gene
93. Defective and nondefective adenovirus vectors for expressing foreign genes in vitro and in vivo
94. Expression of recombinant genes in myocardium in vivo after direct injection of DNA
95. In vivo transfer of a marker gene to study motoneural development
96. Emergence of early region 1 (El)-containing replication competent adenovirus in stocks of replication defective adenovirus recombinants (ΔE1+ΔE3) during multiple passages in 293 cells
97. An autosomal transcript in skeletal muscle with homology to dystrophin
98. The polypeptides of adenovirus. II. Soluble proteins cores top components and the structure of the virion
99. Adenovirus vaccine vectors expressing hepatitis B surface antigen: importance of regulatory elements in the adenovirus major late intron
100. An adenovirus vector system used to express polyoma virus tumor antigens
101. Construction of a helper-free recombinant adenovirus that expresses polyomavirus large T antigen
102. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies
103. Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B
104. Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway
105. Evaluation of the efficacy and safety of in vitro adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA
106. An explanation for the phenotypic differences between patients bearing partial deletion of the DMD locus
107. Resolving the functions of of overlapping genes by site-specific mutagenesis at a mRNA splice site
108. Cell and gene therapy in Duchenne Muscular dystrophy
109. The basic science of gene therapy
110. Regulation of early adenovirus gene expression
111. Molecular biology of muscle — the generation of protein diversity
112. Localization of muscle gene products in nuclear domains
113. Virusreceptor interaction in the adenovirus system: Characterization of positive cooperative binding of virions on tn HeLa cells
114. Adenovirus assay by the fluorescent cellcounting procedure
115. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule
116. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems
117. Short and long term dissemination of deletion mutants of adenovirus in permissive (cotton rat) and non-permissive (mouse) species
118. Adenovirus as an expression vector in muscle cells in vivo
119. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice
120. Homologous recombination of adenovirus DNA in mammalian cells: enhanced recombination following UV-irradiation of the virus
121. Development of analysis of recombinant adenoviruses for gene therapy of cystic fibrosis
122. Adenoviral vectors as functional retrograde neuronal tracers
123. Preferential integration of the Ad5/SV 40 hybrid virus at the highly recombinogenic human chromosomal site 1p36
124. The gene for neural apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy
125. Covalently closed circles of adenovirus 5 DNA
126. Gene delivery to spinal motor neurons
127. Retroviral vector-mediated gene transfer into human primary myogenic cells lead to expression in muscle fibers in vivo
128. Mechanism of enhancement of DNA expression consequent to cointernalization of a replication-deficient adenovirus and unmodified plasmid DNA
129. Intraperitoneal in vivo gene therapy to deliver α1-antitrypsin to the systemic circulation
130. An error in dystrophin mRNA processing in golden retriever muscular dystrophy an animal homologue of Duchenne muscular dystrophy
131. Functional analysis of adenovirus-5 host-range deletion mutants defective for transformation of rat embryo cells
132. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation
133. The anatomy and physiology of the motor unit
134. Expression of alpha and beta myosin heavy chain in the rat ventricular cardiac muscle cell
135. Overexpression of the human vitamin D3 receptor in mammalian cells using recombinant adenovirus vectors
136. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice
137. NF-IL6 a member of C/EBP family regulates E1A responsive promoters in absence of E1A
138. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy
139. Functions of the adenovirus tumour antigens
140. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector
141. Feasibility of adenovirus mediated gene transfer in vivo
142. Widespread long-term gene transfer to mouse skeletal muscles and heart via an adenovirus vector
143. Gene therapy: the advent of adenovirus
144. Adenovirus VA I RNA is required for efficient translation of viral mRNAs at late times after infection
145. Stable incorporation of a bacterial gene into adult rat muscle in vivo
146. Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis
147. Gene therapy using adenoviral vectors
148. Infection of eukaryotic cells be helper-independent recombinant adenoviruses: early region 1 is not obligatory for integration of viral DNA
149. Nucleotide sequence of adenovirus DNAs
150. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene
151. Gene transfer in regenerating muscle Hum Gene
152. Gene inhibition using antisense oligodeoxynucleotides
153. Coupling of adenovirus to transferrin-polylysin-DNA complexes greatly enhances receptor mediated gene delivery and expression of transfected genes
154. Cell biology of muscle
155. Deletion of the E4 region of the genome produces adenovirus DNA concatemers
156. A cell line that supports the growth of a defective early region 4 deletion mutant of human adenovirus type 2
157. Adenoviral early region 4 is required for efficient viral DNA replication and for late gene expression
158. Human dystrophin expression corrects the myopathic phenotype in transgenic mdx mice
159. Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment
160. Adenovirus proteins that subvert host defenses
161. Direct gene transfer into mouse muscle in vivo
162. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle
163. Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules caveolae of mammalian skeletal muscle
164. Overproduction of the protein product of a nonselected foreign gene carried by an adenovirus vector
165. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardement
166. Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy
167. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung
168. Adenovirus-mediated augmentation of cell transfection with unmodified plasmid vectors
169. Adenovirus vector expressing functional herpes simplex virus ICPO
170. The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle